The analyst suggested a stoploss at Rs 302.

The analyst suggested a stoploss at Rs 302.

The analyst suggested a stoploss at Rs 295.

The analyst suggested a stoploss at Rs 300.

The company’s third quarter result was operationally in line with estimates but a higher tax rate led to a 10% miss on reported profit.

The analyst suggested a stoploss at Rs 296.

The analyst suggested a stoploss at Rs 293.

Citi gave the buy rating after the company and Mylan announced launch of Ogivri in the US.

Abhijit Pathak recommended to keep stoploss at Rs 264.

Buy Biocon Ltd. at a price target of Rs 660.0 and a stop loss at Rs 630 from the entry point.

Buy Biocon Ltd. at a price target of Rs 625.0 and a stop loss at Rs 594 from entry point.

Buy Biocon Ltd. at a price target of Rs 668.0 and a stop loss at Rs 622 from entry point.

Buy Biocon Ltd. at a price target of Rs 642.0 and a stop loss at Rs 606 from entry point.

Buy Biocon Ltd. at a price target of Rs 641.0 and a stop loss at Rs 620 from entry point.

Buy Biocon at a price target of Rs 380 and a stop loss at Rs 363 from entry point.

RUGBY UNION-SCOTLAND/TEAM (UPDATE 1):UPDATE 1-Rugby-Cotter opts for experience against Georgia

RUGBY UNION-SCOTLAND/TEAM (UPDATE 1):UPDATE 1-Rugby-Scotland make four changes for Argentina clash